Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Les Echos investir

December 28, 2019

A potential target

DER AKTIONÄR

December 18, 2019

Biotech secret tip Abivax: Up more than 100% in just two months – will this trend continue?

Edison Investment Research

December 13, 2019

Executive interview with Abivax CEO and CFO at the EKF conference 2019

DER AKTIONÄR

December 4, 2019

Biotech secret tip Abivax Takes off: Monster target price – a share for 2020?

Empowered Patient Podcast

June 5, 2019

Unique Therapy for Multiple Inflammatory Diseases with Dr. Jean-Marc Steens Abivax

  • 1
  • 2

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn